Cardiovascular safety and diabetes drug development

Lancet. 2011 Mar 19;377(9770):977-9. doi: 10.1016/S0140-6736(10)62299-4.
No abstract available

MeSH terms

  • Cardiovascular Diseases / chemically induced
  • Cardiovascular Diseases / prevention & control*
  • Diabetes Mellitus / drug therapy*
  • Drug Approval
  • Drug Design*
  • Guidelines as Topic
  • Humans
  • Hypoglycemic Agents / administration & dosage*
  • Hypoglycemic Agents / adverse effects*
  • Medication Adherence
  • Receptors, Glucagon / agonists
  • Risk Assessment
  • United States
  • United States Food and Drug Administration

Substances

  • Hypoglycemic Agents
  • Receptors, Glucagon